Navigation Links
Penn study shows how electronic medical records can be used to test drug efficacy
Date:2/6/2009

PHILADELPHIA, PA -- For years controversy has surrounded whether electronic medical records (EMR) would lead to increased patient safety, cut medical errors, and reduce healthcare costs. Now, researchers at the University of Pennsylvania School of Medicine have discovered a way to get another bonus from the implementation of electronic medical records: testing the efficacy of treatments for disease.

In the first study of its kind, Richard Tannen, M.D., Professor of Medicine at the University of Pennsylvania School of Medicine, led a team of researchers to find out if patient data, as captured by EMR databases, could be used to obtain vital information as effectively as randomized clinical trials, when evaluating drug therapies. The study appeared online last week in the British Medical Journal.

"Our findings show that if you do studies using EMR databases and you conduct analyses using new biostatistical methods we developed, we get results that are valid," Tannen says. "That's the real message of our paper -- this can work."

In January 2009, President Barack Obama unveiled plans to implement electronic medical records nationwide within five years, arguing that such a plan was crucial in the fight against rising health care costs. Of the nearly $900 billion in Obama's planned stimulus package currently before the United States Senate, $20 billion is proposed for electronic health records.

Tannen says he and his group recognized that the large EMR databases containing compiled medical information could potentially give researchers the ability to study groups reflective of the total population, not just those who participate in clinical trials, and circumvent studies too costly or unethical for clinical trials. However, such databases contain observational information, which critics argue do not offer the same level of control as randomized trials.

"Our study cautiously, yet strongly, suggests that enormous
'/>"/>

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Michigan are pleased to announce an agreement to publish ... Endocrinology , which is now open for submissions and ... , The journal is led by Editor-in-Chief, Meng ... Metabolism, Endocrinology, and Diabetes, at the University of Michigan, ... international Editorial Board. , Clinical Diabetes and ...
(Date:9/30/2014)... cells cannot multiply and cardiac muscles contain few ... itself after a heart attack. Now Tel Aviv ... standard in cardiac tissue engineering. , Dr. Tal ... TAU,s Department of Biotechnology, Department of Materials Science ... have been developing sophisticated micro- and nanotechnological tools ...
(Date:9/30/2014)... NY Four scientists at Cold Spring Harbor Laboratory ... under two new CSHL grants announced in Washington today. ... by the National Institutes of Health (NIH), totaling $46 ... initial funding for the BRAIN Initiative. ... was launched by the President in the spring of ...
(Date:9/30/2014)... A new report launched today by the ... Study on Ageing) conducted by academics from the ... Ireland, has highlighted the serious, complex and unique ... population. , The IDS-TILDA study is the first ... only one in the world with the ability ...
(Date:9/30/2014)... SIMpalm, the top iPhone app development ... great social networking music sharing experience. Lyricz LLC officially ... and iPod touch®. The App allows users to take ... pre-populated ITunes account. This app also gives users the ... photo of their choice to the snippet of selected ...
Breaking Medicine News(10 mins):Health News:BioMed Central to publish open access journal in collaboration with the University of Michigan 2Health News:A heartbeat away? Hybrid 'patch' could replace transplants 2Health News:4 Cold Spring Harbor Laboratory scientists will contribute to President Obama's BRAIN Initiative under new NIH grants 2Health News:4 Cold Spring Harbor Laboratory scientists will contribute to President Obama's BRAIN Initiative under new NIH grants 3Health News:Longitudinal report shows challenging reality of ageing with an intellectual disability 2Health News:Longitudinal report shows challenging reality of ageing with an intellectual disability 3Health News:Longitudinal report shows challenging reality of ageing with an intellectual disability 4Health News:LYRICZ App for iPhone®, Helps You Share Images with Music to Inspire and Influence 2
... chronically ill Medicaid patients designed to provide care ... Jan. 27 Chronically ill members ... Health Insurance plans (CHIP) in Philadelphia are now ... homes, thanks to an innovative new partnership with ...
... A study by healthcare market research firm Manhattan Research ... support for continuing medical education (CME) funding. The results ... in the medical community about the role of commercial ... positions of those who actually use continuing medical education, ...
... thinner, Munro & Associates steps up for their customersTROY, ... and great for our customers," says Sandy Munro, Founder ... deliver 21 years worth of experience more efficiently and ... in today,s climate could spell disaster. No company can ...
... in fruit flies has led researchers to a sensitive and ... common type of kidney cancer. In the journal Science ... the University of Chicago shows that the biomarker known as ... cell carcinomas but not by normal kidney tissue. , Physicians ...
... state, construct prison health care centers throughout California.LOS ANGELES, ... this week to prevent a federal judge and his ... treasury for the sole purpose of reconstructing the state,s ... opposes the proposal to construct seven new prison facilities, ...
... Ages Two Years and Older , FT. WASHINGTON, Pa., ... Inc., today announced the availability of Children,s ZYRTEC(R) Allergy ... flavor product used to treat perennial and seasonal allergic ... ages two years and older. Children,s ZYRTEC(R) Allergy ...
Cached Medicine News:Health News:Physician Home Visits Centerpiece of New AmeriChoice and INSPIRIS Partnership in Philadelphia 2Health News:Physician Home Visits Centerpiece of New AmeriChoice and INSPIRIS Partnership in Philadelphia 3Health News:Manhattan Research Survey Finds That Physicians Overwhelmingly Support Commercially-Funded Continuing Medical Education 2Health News:Manhattan Research Survey Finds That Physicians Overwhelmingly Support Commercially-Funded Continuing Medical Education 3Health News:Survival Favors the Prepared 2Health News:Roadkill study could speed detection of kidney cancer 2Health News:Ventura County Taxpayers' Group Files Suit to Stop State-of-the-Art Hospitals for Incarcerated Felons 2Health News:Children's Sugar-Free, Dye-Free ZYRTEC(R) Allergy Syrup Now Available 2Health News:Children's Sugar-Free, Dye-Free ZYRTEC(R) Allergy Syrup Now Available 3
(Date:9/30/2014)... 30, 2014 Summary This report ... pharmaceutical companies regarding their Information & Communications Technology ... companies currently allocate their ICT budgets across the ... IT services, communications, and consulting. Key ... companies highlights that X% of respondents anticipate an ...
(Date:9/30/2014)... Investor-Edge has initiated coverage on the following ... Zentaris Inc. (NASDAQ: AEZS ), OPKO Health ... (NYSE MKT: NAVB), and Exact Sciences Corporation (NASDAQ: EXAS). ... at: http://investor-edge.com/register . On Monday, September ... 0.14%, the Dow Jones Industrial Average finished the day ...
(Date:9/30/2014)... 2014  Come fall, many children, teenagers, and even ... want to be for Halloween. And, a number of ... contact lenses bought without a prescription. Halloween, ... purchase and wear contact lenses without a prescription. According ... consumer survey, 17 percent of Americans have worn ...
Breaking Medicine Technology:ICT investment trends in pharmaceuticals - Enterprise ICT spending patterns through to the end of 2015 2ICT investment trends in pharmaceuticals - Enterprise ICT spending patterns through to the end of 2015 3Watch List for Biotech Equities - Immunomedics, Aeterna Zentaris, OPKO Health, Navidea Biopharma, and Exact Sciences 2Watch List for Biotech Equities - Immunomedics, Aeterna Zentaris, OPKO Health, Navidea Biopharma, and Exact Sciences 3Watch List for Biotech Equities - Immunomedics, Aeterna Zentaris, OPKO Health, Navidea Biopharma, and Exact Sciences 4Watch List for Biotech Equities - Immunomedics, Aeterna Zentaris, OPKO Health, Navidea Biopharma, and Exact Sciences 5The Spooky Truth: What You Need To Know About Contact Lens Hygiene 2The Spooky Truth: What You Need To Know About Contact Lens Hygiene 3
... SAN DIEGO, Sept. 26, 2011 Elevation Pharmaceuticals, Inc., ... aerosol therapies for patients with respiratory diseases, today announced ... and Chief Business Officer and Pravin Soni, PhD, as ... created positions. The company also announced that it drew ...
... 26, 2011 Clermont Pharmaceuticals, Inc., a ... positive results from a phase III trial ... latanoprost was compared to Xalatan® (latanoprost ophthalmic ... glaucoma.  Non-preserved latanoprost achieved the primary efficacy ...
Cached Medicine Technology:Elevation Pharmaceuticals Strengthens Management Team with Appointment of Executives 2Elevation Pharmaceuticals Strengthens Management Team with Appointment of Executives 3Clermont Pharmaceuticals Reports Positive Phase III Results for Drug to Treat Glaucoma 2
The Spex SkinSkan is the only in-vivo, fibre-optic spectrofluorometer designed specifically for skin-fluorescence measurements. It is also ideal for many remote sensing steady-state fluorescence appl...
The unique RF-1501 optical design provides exceptional sensitivity in an incredibly compact instrument....
... Quantitation of DNA, RNA, Or Fluorescent Tags. Accurate ... is critical to life science research. The RF-Mini ... measure quantities as small as 1ng/ml of DNA ... of excitation and emission filters, the RF-Mini 150 ...
The Fluoroskan Ascent FL is equipped with both fluorometric and luminometric measurement technologies, providing a full coverage for fluorometric, glow and flash luminometric applications even in the...
Medicine Products: